RPSG VENTURES LIMITED — Capital/Financing Update 2021

Mar 8, 2021

==> picture [71 x 6] intentionally omitted <==

==> picture [25 x 11] intentionally omitted <==

==> picture [115 x 9] intentionally omitted <==

	Annexure A	Annexure A
Sr.	DetailsofEvents thatneedtobe	Informationofsuch events(s)
No.	provided
a)	nameofthetargetentity, detailsinbrief	HerbolabIndiaPrivate Limited ('Herbolab'), a
	suchassize,turnoveretc.;	manufacturerofAyurvedamedicinesand
		productsunderthebrandname"Dr. Vaidya's".
		Totalrevenueofthetargetentityfortheyear
		ended:
		31stMarch2020= INR 16,33,16,371 / -(Audited)
b)	whethertheacquisitionwouldfall	Herbolabis a SubsidiaryCompanyofRPSG
	withinrelatedpartytransaction(s)and	VenturesLimited('theCompany')andthe
	whetherthepromoter/promoter	Company'sshareholdinginHerbolabpriorto
	group/groupcompanieshaveany	today'sacquisitionwas64.63%. After acquisition
	interestintheentitybeingacquired?	of 35.37%ofHerbolab' sequitysharesfromthe
		sellers, Herbolab becomes awhollyowned
	Ifyes,natureofinterestanddetails	subsidiaryoftheCompany.Theabove
	thereofandwhetherthesameisdoneat	mentionedacquisition isnotarelatedparty
	"arm'slength";	transaction.
c)	industrytowhichtheentitybeing	ManufacturingofAyurvedamedicinesand
	acquiredbelongs;	products.
d)	objectsandeffects of acquisition	TheinvestmentinHerbolabwillhelpthe
	(includingbutnotlimitedto, disclosure	Companytoexpandits existing portfolio into
	ofreasonsfor acquisitionoftarget	ayurvedicproductsmanufacturingsegment.
	entity,ifits business isoutsidethemain	This acquisition willbringinmanysynergiesin
	lineofbusinessofthe Company);	theCompany'sbusinessandlong-term
		strategies.
e)	briefdetailsofanygovernmentalor	Noapprovalrequired
	regulatoryapprovalsrequiredforthe
	acquisition;
f)	indicativetimeperiodforcompletion	Simultaneouslywithexecution oftheinvestment
	ofthe acquisition;	agreement
		1
		<br><br>l
	RPSGVENT	URESLIMITED~|

g)	natureofconsideration -whether cash	Cashconsiderationpaidthroughbankaccount
	considerationorshareswapanddetails	transfer.
	ofthesame
h)	cost of acquisitionorthepriceatwhich	5,00,000shares acquired for INR 50,80,00,000
	thesharesareacquired;
i)	percentageof shareholding/ control	5,00,000shares
	acquiredand/ ornumberof shares
	acquired;
j)	briefbackgroundabouttheentity	Herbolabwasincorporatedon15May1980and
	acquiredintermsofproducts/lineof	hasbeenengagedinthemanufacturingand
	businessacquired,dateof	sellingofAyurvedic medicinesandproducts.
	incorporation, historyoflast3years	HerbolabhaspresencepanIndiaandits total
	turnover,countryinwhichthe	revenuefortheprevious3 (three) financial years
	acquired entityhaspresence andany	isas follows:
	othersignificant information (in brief);
		31st March 2020= Rs. 16,33,16,371 / - (Audited)
		31stMarch, 2019= Rs. 2,04,17,905 / - (Audited)
		31st March, 2018: Rs. 86,83,525/ - (Audited)